Genetic and Immunity in Heart Failure

RecruitingOBSERVATIONAL
Enrollment

215

Participants

Timeline

Start Date

February 4, 2025

Primary Completion Date

July 15, 2026

Study Completion Date

September 30, 2026

Conditions
Heart Failure
Interventions
GENETIC

Evaluation of HS1,2 polymorphisms

"Echocardiograms will be performed by experienced operators of the echocardiography service.~Inflammatory profile. A single additional blood sample (3 cc) will be collected. Plasma will be isolated from whole blood to determine pro-inflammatory cytokines.~Immunoprofile: Circulating lymphocytes will be separated according to Ficoll gradient (into the two different components of immunity (B and T lymphocytes) with different inflammatory phenotypes.~Evaluation of HS1,2 polymorphisms and estrogen levels: DNA purifications and amplifications will be performed from an aliquot of the single whole blood sample. Genomic DNA will be isolated using the QIAamp DNA Mini and Blood Mini kit (QIAGEN Hilden, Germany) according to the manufacturer's protocol. 9 single nucleotide polymorphisms (SNPs) in four specific polymorphic regions of the 3'-1 Regulatory Region (3'RR-1) of the human immunoglobulin (IgH) heavy chain locus will be sequenced."

Trial Locations (2)

Unknown

ACTIVE_NOT_RECRUITING

IRCCS Casa Sollievo della Sofferenza, San Giovanni Rotondo

00168

RECRUITING

Fondazione Policlinico Universitario A. Gemelli IRCCS, UOC Medicina Genarale e dell'Invecchiamento, Rome

All Listed Sponsors
lead

Fondazione Policlinico Universitario Agostino Gemelli IRCCS

OTHER